Accellix Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 60

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $50.3M

Accellix General Information

Description

Developer of an automated cell phenotyping platform designed for point-of-need environments. The company offers a system that automates sample preparation, measurement, and data analysis for cell therapy manufacturing quality control and blood-derived apheresis characterization, enabling medical companies to perform cell phenotyping outside centralized laboratories and support decision-making across development, manufacturing, and product release workflows.

Contact Information

Formerly Known As
LeukoDx, Leukodx, Lp
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 2385 Bering Drive
  • San Jose, CA 95131
  • United States
+1 (650)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Parent Company
Vertical(s)
Corporate Office
  • 2385 Bering Drive
  • San Jose, CA 95131
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Accellix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 22-Jan-2026 $50.3M Completed Generating Revenue
8. Later Stage VC 13-Dec-2021 Completed Generating Revenue
7. Later Stage VC (Series D) 11-Jun-2020 Completed Generating Revenue
6. Debt - PPP 27-Apr-2020 Completed Generating Revenue
5. Later Stage VC 16-Jun-2014 Completed Generating Revenue
4. Later Stage VC 18-Apr-2012 Completed Generating Revenue
3. Early Stage VC 02-Aug-2010 Completed Generating Revenue
2. Seed Round 27-Jun-2010 $120K $497K Completed Generating Revenue
1. Seed Round 31-Jul-2009 $377K $377K Completed Generating Revenue
To view Accellix’s complete valuation and funding history, request access »

Accellix Patents

Accellix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021356770-A1 System for determining a biological condition and cartridge therefor Active 07-Oct-2020
AU-2021356770-B2 System for determining a biological condition and cartridge therefor Active 07-Oct-2020
AU-2025210862-A1 System for determining a biological condition and cartridge therefor Pending 07-Oct-2020
EP-4225501-A1 System for determining a biological condition and cartridge therefor Pending 07-Oct-2020
EP-4225501-A4 System for determining a biological condition and cartridge therefor Pending 07-Oct-2020 B01L3/502715
To view Accellix’s complete patent history, request access »

Accellix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Accellix Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Axcel Partners PE/Buyout Minority
BroadOak Capital Partners Growth/Expansion Minority
Current Yield with Participation Fund PE/Buyout Minority
To view Accellix’s complete investors history, request access »

Accellix FAQs

  • When was Accellix founded?

    Accellix was founded in 2007.

  • Where is Accellix headquartered?

    Accellix is headquartered in San Jose, CA.

  • What is the size of Accellix?

    Accellix has 60 total employees.

  • What industry is Accellix in?

    Accellix’s primary industry is Diagnostic Equipment.

  • Is Accellix a private or public company?

    Accellix is a Private company.

  • What is the current valuation of Accellix?

    The current valuation of Accellix is .

  • What is Accellix’s current revenue?

    The current revenue for Accellix is .

  • How much funding has Accellix raised over time?

    Accellix has raised $37.3M.

  • Who are Accellix’s investors?

    Axcel Partners, BroadOak Capital Partners, and Current Yield with Participation Fund have invested in Accellix.

  • When was Accellix acquired?

    Accellix was acquired on 22-Jan-2026.

  • Who acquired Accellix?

    Accellix was acquired by BioMérieux.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process